John Reed at JPM 2019. Jeff Rumans for Endpoints News
Sanofi's John Reed continues to reorganize R&D, cutting 466 jobs while boosting cancer, gene therapy research
The R&D reorganization inside Sanofi is continuing, more than a year after the pharma giant brought in John Reed to head the research arm of the Paris-based company.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.